PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED

PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED was reported 73 times

PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 7 0.0003
1 CTLA-4-directed Blocking Antibody [EPC] 7 0.0001
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 9 0.0001
3 Bile Acid [EPC] 2 0.0001
4 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 3 0.0001
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 8 0.0000
6 Kinase Inhibitor [EPC] 22 0.0000
7 Radiographic Contrast Agent [EPC] 1 0.0000
8 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
9 Factor Xa Inhibitor [EPC] 8 0.0000
10 Rifamycin Antibacterial [EPC] 1 0.0000
11 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
12 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
13 Nucleoside Analog Antiviral [EPC] 1 0.0000
14 Integrin Receptor Antagonist [EPC] 1 0.0000
15 Nitrate Vasodilator [EPC] 1 0.0000
16 Purine Antimetabolite [EPC] 1 0.0000
17 Aminosalicylate [EPC] 1 0.0000
18 Mood Stabilizer [EPC] 2 0.0000
19 Sulfonylurea [EPC] 1 0.0000
20 Platinum-based Drug [EPC] 2 0.0000
21 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
22 alpha-Adrenergic Blocker [EPC] 1 0.0000
23 Aldosterone Antagonist [EPC] 1 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
25 RANK Ligand Inhibitor [EPC] 1 0.0000
26 Anti-epileptic Agent [EPC] 1 0.0000
27 Proton Pump Inhibitor [EPC] 2 0.0000
28 Osmotic Laxative [EPC] 1 0.0000
29 beta-Adrenergic Blocker [EPC] 1 0.0000
30 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
31 Corticosteroid [EPC] 2 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 1 0.0000